B. Fenton Hall

TL;DR: The Malaria Eradication Research Agenda initiative and the set of articles published in this PLoS Medicine Supplement that distill the research questions key to malaria eradication are introduced.

TL;DR: The result is a research and development agenda to accelerate malaria elimination and, in the longer term, transform the malaria community’s ability to eradicate it globally.

TL;DR: This is the first demonstration in humans that a peptide vaccine containing minimal T and B cell epitopes composed of only 5 amino acids can elicit antibody titers comparable to multiple exposures to irradiated P. falciparum-infected mosquitoes.

TL;DR: It was concluded that although schistosomiasis elimination in some focal areas may be achievable through current mass drug administration programs, global control and elimination will face several significant scientific and operational challenges, and will require an integrated approach with other, additional interventions.

TL;DR: This data indicates that malaria persists unabated in many parts of the world today, with the great majority of which occur in children younger than 5 years of age and in young, pregnant women.